Pharmacytimes: Condition Center: Acid Reflux Acid Reflux en-us Fri, 30 Jan 2015 11:21:41 UTC Fri, 30 Jan 2015 11:21:41 UTC Chronic PPI Use Could Lead to Esophageal Adenocarcinoma Barrett’s esophagus (BE) is a condition in which tissue in the esophagus is replaced by tissue similar to that found in the intestinal lining, which predisposes a patient to esophageal adenocarcinoma (EAC). Tue, 27 Jan 2015 11:00:00 UTC FDA Approves First Nexium Generic The FDA today approved Ivax Pharmaceuticals’ esomeprazole magnesium delayed-release capsules, the first generic version of AstraZeneca’s proton pump inhibitor Nexium, for the treatment of gastroesophageal reflux disease in patients aged >1 year. Mon, 26 Jan 2015 07:33:00 UTC Weight Loss Reduces Gastric Reflux Symptoms After ringing in the New Year, Americans from all walks of life have started dieting. For the 10% to 20% of Americans who experience gastric reflux, such weight loss may be the key to reducing associated symptoms. Thu, 08 Jan 2015 02:00:28 UTC Patient Complexity Creates Barriers to PPI Deprescribing A recent review of inappropriate prescribing among hospitalized older adults revealed that proton pump inhibitors follow only opiates and benzodiazepines as the most frequently misprescribed medications. Sat, 29 Nov 2014 03:02:01 UTC PPIs Increase Risks for Infection, Vitamin Deficiency A new Mayo Clinic study published in Microbiome shows that patients with acid reflux who regularly receive proton pump inhibitors have less diverse gut bacteria, which heightens their risk for bone fractures, vitamin deficiencies, and infections such as Clostridium difficile and pneumonia. Wed, 26 Nov 2014 10:01:01 UTC Down-Titration of PPIs After GERD Symptom Control Patients on 20-mg maintenance doses of esomeprazole reported no more than mild symptom severity. Fri, 07 Nov 2014 04:04:01 UTC Obese Asthmatics Overuse Rescue Medications As a result of confusing sensations of breathlessness with asthma symptoms, overweight and obese children tend to report poorer asthma control and overuse rescue medications. Thu, 23 Oct 2014 06:00:01 UTC Predicting Partial Response to PPI Therapy As nearly one-third of patients with gastroesophageal reflux disease are partial responders to proton pump inhibitors (PPIs), health care professionals could benefit from reliable methods that predict who will respond to PPIs and who will not. Thu, 16 Oct 2014 06:42:01 UTC New Portal Makes Patient-Reported Gastroesophageal Reflux Disease Outcomes Easier to Assess The My GI Health tool tracks symptoms of gastroesophageal reflux disease over time, helping clinicians save time and improve patient care. Sun, 14 Sep 2014 05:37:25 UTC Looking for Nonpharmacologic Interventions for GERD? Try Diet GERD patients are not following recommendations to avoid acid-triggering foods, according to a recent study. Fri, 22 Aug 2014 07:32:01 UTC Reflux Esophagitis: Sometimes Healing Takes Time Recent study on healing rates of reflux esophagitis patients suggests that some refractory patients may heal with extended acid suppression treatment. Tue, 29 Jul 2014 01:56:01 UTC Does Gobbling Food Increase Reflux? A recent study indicates that eating meals quickly does not increase reflux episodes in gastroesophageal reflux disease patients. Thu, 03 Jul 2014 03:05:36 UTC Rates of Anti-Reflux Procedures Not Consistent Among Pediatric Hospitals A recent study found that rates of anti-reflux procedures vary greatly among pediatric hospitals and that there are no standardized guidelines for referrals for such procedures. Mon, 09 Jun 2014 07:34:51 UTC Proton Pump Inhibitors Linked to Non-Specific Gastric Inflammation in Children Children exposed to PPIs for more than 6 weeks are found to have an increased risk of non-specific gastric inflammation. Mon, 09 Jun 2014 07:20:35 UTC A New Frontier in GERD: The Gastric Pocket Researchers examined the effects of proton pump inhibitors on the highly acidic pocket of gastric juice at the esophagogastric junction. Fri, 06 Jun 2014 07:53:01 UTC Kids and GERD: Are PPIs Safe? Studies support short-term use of proton pump inhibitors in children, but additional clinical trials are needed to determine their long-term safety. Fri, 06 Jun 2014 06:13:48 UTC From Acid Reflux to Premalignant Condition: Screening Challenges The use of prediction models can help clinicians identify patients who are unlikely to benefit from invasive investigation for Barrett’s esophagus. Thu, 05 Jun 2014 07:57:01 UTC Who Responds to PPIs? A group of German researchers investigated predictors of which patients with gastroesophageal reflux disease symptoms were most likely to respond to proton pump inhibitors. Sat, 31 May 2014 04:01:01 UTC Long-Term PPI Use or Fundoplication for GERD Treatment Experts discuss the pros and cons of long-term proton pump inhibitor use and surgical fundoplication in patients with gastroesophageal reflux disease. Fri, 30 May 2014 09:28:54 UTC Acid Reflux: More Than a Nuisance Acid reflux is frequently dismissed as a nuisance, but can lead to serious damage to the stomach and esophagus if not properly treated. Fri, 30 May 2014 09:19:26 UTC